Quitting Ozempic or Wegovy can lead to rapid weight gain and health issues. Why are these medications vital for long-term weight management?

Acute pancreatitis is a sudden inflammation of the pancreas, an organ located behind the stomach that plays a key role in digestion ...

According to the Centers for Disease Control and Prevention, 41.9 percent of U.S. adults were obese from 2017 to 2020.

The UK pharmaceutical giant AstraZeneca is doubling down on its commitment to the Chinese drugmaker CSPC Pharmaceutical Group ...

Participating Medicare Part D plans can officially begin covering weight-loss treatment in 2027. The initiative falls under CMS’ voluntary “Better Approaches to Lifestyle and Nutrition for ...

Hims & Hers is returning to the Super Bowl — one year after its debut spot kicked up a storm of controversy. The telehealth ...

This years 2026 ASCO Gastrointestinal Cancers Symposium was packed with practice-shaping data across colorectal and upper ...

Winfrey has openly discussed her weight-loss journey and the use of prescription GLP-1 medications in recent years.

The firm has announced four new US manufacturing sites since February 2025.

Long before Ozempic and Wegovy became household names, a Department of Veterans Affairs researcher studying Gila monster ...

Kayshild is recommended for adults with non-cirrhotic metabolic dysfunction-associated steatohepatitis and ...

This session pulls back the curtain on creative funding strategies designed to de-risk GLP-1 coverage, allowing you to bring ...